The Medical Letter on Drugs and Therapeutics
FROM
ISSUE
1104
May 14, 2001
View Complete Issue         Table of Contents 2019 
GlucoWatch Biographer: A Noninvasive Glucose Monitoring Device
Subscribers: Log in to read full article.  Not a subscriber?  Subscribe or purchase article.
GlucoWatch Biographer: A Noninvasive Glucose Monitoring Device
May 14, 2001 (Issue: 1104)
An automatic, noninvasive, glucose-monitoring device (GlucoWatch Biographer) has been approved for marketing by the FDA. The manufacturer states that it is not meant to replace a regular blood glucose meter.
The Medical Letter is a subscriber-funded nonprofit organization that publishes critical appraisals of new prescription drugs and comparative reviews of drugs for common diseases.

Would you like to read the rest of this article?  Gain access below.

Subscribe
Subscriptions to The Medical Letter on Drugs and Therapeutics include:
  • Print version published and mailed biweekly (26 issues/year)
  • Unlimited online access to current and past issues (1988 - present)
  • Mobile App for iOS, Android, and Kindle Fire
  • FREE online per issue CME/CE
Purchase this article:
Title: GlucoWatch Biographer: A Noninvasive Glucose Monitoring Device
Article code: 1104c
 Electronic, downloadable article - $45


Gain access through your organization
Ask your librarian to consider an Institutional Subscription to The Medical Letter.